These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 5317539)

  • 1. Plasma fractions for the treatment of hemophilia. 1. On the preparation and use of fraction I-O.
    Blombäck M; Blombäck B
    Thromb Diath Haemorrh Suppl; 1969; 35():21-5. PubMed ID: 5317539
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of a single administration of cryoprotein and plasma on factor VIII in hemophilia A].
    Vlcková M; Vorlová Z
    Vnitr Lek; 1980 Nov; 26(11):1101-6. PubMed ID: 6789551
    [No Abstract]   [Full Text] [Related]  

  • 3. Acquired circulating anticoagulants in hemophilia A.
    Strauss HS
    N Engl J Med; 1969 Oct; 281(16):866-73. PubMed ID: 5812255
    [No Abstract]   [Full Text] [Related]  

  • 4. Letter: Blood fractions for haemophilia.
    Lancet; 1974 Jul; 2(7873):155. PubMed ID: 4135512
    [No Abstract]   [Full Text] [Related]  

  • 5. Haemophilia.
    Dormandy KM; Currey HL
    Rep Rheum Dis; 1970 Oct; 42():1-2. PubMed ID: 5493731
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of plasma and/or factor VIII concentrates administration on platelet functions in patients with haemophilia A and von Willebrand's disease (author's transl)].
    Gamba G; Grignani G; Nicolini E; Ascari E
    Haematologica; 1975 Jun; 60(2):168-83. PubMed ID: 808449
    [No Abstract]   [Full Text] [Related]  

  • 7. [Preliminary experience with achieving immune tolerance in patients with hemophilia A and circulating factor VIII inhibitor].
    Scharf R; Kucharski W; Lopaciuk S; Celińska W; Dmytrow A; Domański K; Gonet S; Miastkowski Z; Nowakowska I; Przybylski A
    Acta Haematol Pol; 1991; 22(1):92-9. PubMed ID: 1823972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The laboratory assessment of the efficacy of antihaemophilic therapy.
    Lurie A
    S Afr Med J; 1972 Aug; 46(33):1180-5. PubMed ID: 5079698
    [No Abstract]   [Full Text] [Related]  

  • 9. [Safe and cost-conscious supply of factor-VIII-deficient Swiss hemophiliacs with AHF preparations].
    Stampfli K
    Ther Umsch; 1977 Oct; 34(10):717-24. PubMed ID: 918896
    [No Abstract]   [Full Text] [Related]  

  • 10. Hemophilia prophylaxis with factor VIII concentrate.
    Kasper CK; Dietrich SL; Rapaport SI
    Arch Intern Med; 1970 Jun; 125(6):1004-9. PubMed ID: 4951928
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of continuous and intermittent Factor VIII concentrate therapy in hemophilia A.
    Hathaway WE; Christian MJ; Clarke SL; Hasiba U
    Am J Hematol; 1984 Jul; 17(1):85-8. PubMed ID: 6430068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T-lymphocyte subpopulations in patients with classic hemophilia treated with cryoprecipitate and lyophilized concentrates.
    Menitove JE; Aster RH; Casper JT; Lauer SJ; Gottschall JL; Williams JE; Gill JC; Wheeler DV; Piaskowski V; Kirchner P; Montgomery RR
    N Engl J Med; 1983 Jan; 308(2):83-6. PubMed ID: 6401196
    [No Abstract]   [Full Text] [Related]  

  • 13. [Study of the "in vivo" activity of factor VIII or factor IX after injection of several concentrates: practical applications].
    Allain JP
    Nouv Rev Fr Hematol; 1972; 12(2):241-9. PubMed ID: 4264617
    [No Abstract]   [Full Text] [Related]  

  • 14. Home transfusion for patients with hemophilia A.
    Rabiner SF; Telfer MC
    N Engl J Med; 1970 Nov; 283(19):1011-5. PubMed ID: 5470264
    [No Abstract]   [Full Text] [Related]  

  • 15. [Production of factor VIII preparations and their use in the substitution therapy of hemophilia A].
    Gaerisch F; Stein P
    Z Gesamte Inn Med; 1982 Oct; 37(19):641-4. PubMed ID: 6817530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Approaches to plasma fractionation for improved recovery and the development of potentially useful clinical factors.
    Johnson AJ; Mathews RW; Fulton AJ
    Clin Haematol; 1984 Feb; 13(1):3-15. PubMed ID: 6426834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Substitution treatment in hemophilia. Critical measures and complications].
    Schimpf K
    Wien Med Wochenschr; 1977 Jun; 127(11):329-37. PubMed ID: 878496
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of hemophilia].
    Straub PW
    Dtsch Med Wochenschr; 1969 Sep; 94(37):1885-7. PubMed ID: 5356323
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of hemophilia with glycine-precipitated factor 8.
    Abildgaard CF; Simone JV; Corrigan JJ; Seeler RA; Edelstein G; Vanderheiden J; Schulman I
    N Engl J Med; 1966 Sep; 275(9):471-5. PubMed ID: 5917942
    [No Abstract]   [Full Text] [Related]  

  • 20. Therapeutic plasma fractions and plasma fractionation (prologue).
    Finlayson JS
    Semin Thromb Hemost; 1979; 6(1):1-11. PubMed ID: 42143
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.